Literature DB >> 28292546

Novel insights into host responses and reproductive pathophysiology of porcine reproductive and respiratory syndrome caused by PRRSV-2.

John C S Harding1, Andrea Ladinig2, Predrag Novakovic3, Susan E Detmer4, Jamie M Wilkinson5, Tianfu Yang6, Joan K Lunney7, Graham S Plastow8.   

Abstract

A large challenge experiment using North American porcine reproductive and respiratory virus (PRRSV-2) provided new insights into the pathophysiology of reproductive PRRS. Deep phenotyping of dams and fetuses identified maternal and fetal predictors of PRRS severity and resilience. PRRSV infection resulted in dramatic decreases in all leukocyte subsets by 2days post inoculation. Apoptosis in the interface region was positively related to endometrial vasculitis, viral load in endometrium and fetal thymus, and odds of meconium staining. Viral load at the maternal-fetal interface was a strong predictor of viral load in fetal thymus and odds of fetal death. However, interferon-alpha suppression, a consequence of PRRSV infection, was protective against fetal death. Although the prevalence of fetal lesions was low, their presence in fetal organs and umbilical cord was strongly associated with fetal compromise. Fetal death and viral load clustered in litters suggesting inter-fetal transmission starting from a limited number of index fetuses. Factors associated with index fetal infection are unclear, but large fetuses appear at greater risk. Disease progression in fetuses was associated with an up-regulation of genes associated with inflammation, innate immunity, and cell death signaling, and down-regulation of genes associated with cell cycle and lymphocyte quality. A number of maternal transcriptomic responses were associated with PRRS resilience including higher basal gene expression correlated with platelet function, interferon and pro-inflammatory responses. Twenty-one genomic regions across 10 chromosomes were associated with important traits including fetal viral load, fetal death and viability suggesting that selection for reproductive PRRS resilience may be possible.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cytokine; Fetal; Genomics; Leukocyte; Maternal-fetal interface; Mortality; Porcine reproductive and respiratory syndrome (PRRS); Reproduction; Resilience; Transcriptomics

Mesh:

Year:  2017        PMID: 28292546     DOI: 10.1016/j.vetmic.2017.02.019

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  13 in total

1.  Detection of atypical porcine pestivirus genome in newborn piglets affected by congenital tremor and high preweaning mortality1.

Authors:  Kylee M Sutton; Kevin K Lahmers; Seth P Harris; Hiruni R Wijesena; Benny E Mote; Stephen D Kachman; Tudor Borza; Daniel C Ciobanu
Journal:  J Anim Sci       Date:  2019-10-03       Impact factor: 3.159

2.  Maternal immune activation and dietary soy isoflavone supplementation influence pig immune function but not muscle fiber formation.

Authors:  Erin E Bryan; Xuenan Chen; Brooke Nicole Smith; Ryan Neil Dilger; Anna C Dilger
Journal:  J Anim Sci       Date:  2022-05-01       Impact factor: 3.338

3.  Global miRNA, lncRNA, and mRNA Transcriptome Profiling of Endometrial Epithelial Cells Reveals Genes Related to Porcine Reproductive Failure Caused by Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Kang Zhang; Lijiang Ge; Shasha Dong; Ying Liu; Dong Wang; Chunyan Zhou; Cai Ma; Yanchao Wang; Feng Su; Yunliang Jiang
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 4.  Key Gaps in the Knowledge of the Porcine Respiratory Reproductive Syndrome Virus (PRRSV).

Authors:  Sergio Montaner-Tarbes; Hernando A Del Portillo; María Montoya; Lorenzo Fraile
Journal:  Front Vet Sci       Date:  2019-02-20

5.  Highly Efficient Generation of Pigs Harboring a Partial Deletion of the CD163 SRCR5 Domain, Which Are Fully Resistant to Porcine Reproductive and Respiratory Syndrome Virus 2 Infection.

Authors:  Chunhe Guo; Min Wang; Zhenbang Zhu; Sheng He; Hongbo Liu; Xiaofeng Liu; Xuan Shi; Tao Tang; Piao Yu; Jianhua Zeng; Linfang Yang; Yongchang Cao; Yaosheng Chen; Xiaohong Liu; Zuyong He
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561

6.  Nuclear localization signal in TRIM22 is essential for inhibition of type 2 porcine reproductive and respiratory syndrome virus replication in MARC-145 cells.

Authors:  Huiyuan Jing; Ran Tao; Nan Dong; Sufang Cao; Yanting Sun; Wenting Ke; Yang Li; Jinhe Wang; Yan Zhang; Hui Huang; Wang Dong
Journal:  Virus Genes       Date:  2019-08-02       Impact factor: 2.332

7.  Nucleotide-binding oligomerization domain-like receptor X1 restricts porcine reproductive and respiratory syndrome virus-2 replication by interacting with viral Nsp9.

Authors:  Huiyuan Jing; Tao Song; Sufang Cao; Yanting Sun; Jinhe Wang; Wang Dong; Yan Zhang; Zhen Ding; Ting Wang; Zhao Xing; Wenqi Bao
Journal:  Virus Res       Date:  2019-05-24       Impact factor: 3.303

8.  Samples sizes required to accurately quantify viral load and histologic lesion severity at the maternal-fetal interface of PRRSV-inoculated pregnant gilts.

Authors:  Carolina M Malgarin; Javier B Zarate; Predrag Novakovic; Susan E Detmer; Daniel J MacPhee; John C S Harding
Journal:  J Vet Diagn Invest       Date:  2021-01-15       Impact factor: 1.279

9.  Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection.

Authors:  Angelica Van Goor; Alex Pasternak; Kristen Walker; Linjun Hong; Carolina Malgarin; Daniel J MacPhee; John C S Harding; Joan K Lunney
Journal:  BMC Genomics       Date:  2020-11-04       Impact factor: 3.969

10.  Using PRRSV-Resilient Sows Improve Performance in Endemic Infected Farms with Recurrent Outbreaks.

Authors:  Gloria Abella; Adela Pagès-Bernaus; Joan Estany; Ramona Natacha Pena; Lorenzo Fraile; Lluis Miquel Plà-Aragonés
Journal:  Animals (Basel)       Date:  2021-03-08       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.